VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 43 filers reported holding VIRACTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $300,114 | -26.2% | 288,571 | 0.0% | 0.12% | -37.7% |
| Q2 2023 | $406,885 | -11.3% | 288,571 | 0.0% | 0.20% | -10.0% |
| Q1 2023 | $458,828 | +8.9% | 288,571 | 0.0% | 0.22% | -20.5% |
| Q4 2022 | $421,314 | -65.8% | 288,571 | 0.0% | 0.28% | -66.0% |
| Q3 2022 | $1,232,000 | +10.0% | 288,571 | 0.0% | 0.82% | +2.4% |
| Q2 2022 | $1,120,000 | -18.5% | 288,571 | 0.0% | 0.80% | +7.8% |
| Q1 2022 | $1,374,000 | +30.5% | 288,571 | 0.0% | 0.74% | +99.7% |
| Q4 2021 | $1,053,000 | -54.5% | 288,571 | 0.0% | 0.37% | -19.5% |
| Q3 2021 | $2,314,000 | -29.3% | 288,571 | 0.0% | 0.46% | -12.0% |
| Q2 2021 | $3,272,000 | – | 288,571 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 288,571 | $1,232,000 | 0.82% |
| Samsara BioCapital, LLC | 689,709 | $2,945,000 | 0.69% |
| BVF INC/IL | 3,614,662 | $15,435,000 | 0.64% |
| Rubric Capital Management LP | 994,801 | $4,248,000 | 0.21% |
| HAMILTON LANE ADVISORS LLC | 35,791 | $153,000 | 0.06% |
| MAI Capital Management | 637,641 | $2,723,000 | 0.05% |
| Jasper Ridge Partners, L.P. | 92,939 | $397,000 | 0.03% |
| BOURGEON CAPITAL MANAGEMENT LLC | 20,500 | $88,000 | 0.02% |
| Ergoteles LLC | 132,636 | $566,000 | 0.02% |
| Laurion Capital Management LP | 698,000 | $2,980,000 | 0.02% |